Comparator: placebo / Duration of Treatment: 1 day

DRUG2 trials

Sponsors

Organon and Co

Conditions

Migraine

Phase 3

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

CompletedNCT00092963

Organon and CoMigraine

Start: 2004-08-17End: 2005-01-14Updated: 2024-08-14

Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

CompletedNCT00095004

Organon and CoMigraine

Start: 2004-10-21End: 2005-04-04Updated: 2024-08-14